Metformin in cancer immunotherapy: knowledge mapping of an evolving field through bibliometric analysis (2007-2026).
The convergence of metformin and cancer immunotherapy has recently gained intense global interest, driven by evidence that metformin can remodel the tumor immune microenvironment and potentiate immune-based treatments. No bibliometric study has yet mapped this rapidly expanding field. We searched the Web of Science Cor...